Edible composition comprising recombinant human secretory protein
Patent Information
- Application Number
- EP2023853516
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-08-11
- Filing Date
- 2023-08-09
- Publication Date
- 2025-06-18
AI Technical Summary
Current infant formulas rely on bovine milk proteins, which differ from human breast milk proteins, leading to metabolic stress and health disparities between breastfed and formula-fed infants due to the lack of immunomodulatory benefits from human secretory molecules like whey proteins.
Development of edible compositions containing recombinant human secretory proteins, such as lactoferrin, combined with human milk oligosaccharides, probiotics, and other nutrients to replicate the nutritional and immunomodulatory benefits of human breast milk.
Provides infants with the immunomodulatory and nutritional benefits of human breast milk, reducing metabolic stress and health disparities by using recombinant human secretory proteins in infant formulas.
Smart Images

Figure IMGF000028_0001 
Figure IMGF000029_0001 
Figure IMGF000031_0001